TABLE 2.
Role of MalQ in controlling endogenous glycogen-derived maltotriose-dependent mal gene expression
| Straina | Additional genotype | MalK-LacZ activity |
|---|---|---|
| TB04 | malZ | 2.51 |
| MAD104 | malZ glk15::Tn10 (Cam) vector | 4.21 |
| CL28 | malZ Δglk | 4.17 |
| MAD104 | malZ glk15::Tn10 (Cam) pglk+ | 0.08 |
| CL28 | malZ Δglk vector | 4.35 |
| CL28 | malZ Δglk pglk+ | 0.07 |
| MAD107 | malZ glk15::Tn10 (Cam) malQ vector | 6.73 |
| MAD107 | malZ glk15::Tn10 (Cam) malQ pglk+ | 4.18 |
| RD129 | malZ malP malQ vector | 6.90 |
| RD129 | malZ malP malQpglk+ | 3.39 |
a
All strains are derivatives of BRE1162 (malK-lacZ malQ+ malP+ glgA+). The strains were grown in MMA containing 1% (wt/vol) CAA.